VG Life Sciences Inc. VGLS OTC

VG Life Sciences Inc. (VGLS) generated $-6.19K in operating cash flow for quarter ending 2024-03-31. After capital expenditures of $0.00, free cash flow was $-6.19K.

Cash conversion ratio was -0x, suggesting some earnings are non-cash.

Criteria supported by this page:

• HEALTH (0/100, Fail) — weak cash flow raises concerns about debt servicing
• MOAT (28/100, Fail) — limited free cash flow weakens the competitive position
• INCOME (?/100) — Cash conversion ratio was -0x suggests some earnings are non-cash items

Overall SharesGrow Score: 52/100 with 2/7 criteria passed.